Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post Market Study of Exablate Model 4000 Type 1.0/1.1 Following the Treatment of Neuropathic Pain

NCT04649554 is registered in ClinicalTrials.gov with InSightec as lead sponsor.

NCT NCT04649554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04649554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post Market Study of Exablate Model 4000 Type 1.0/1.1 Following the Treatment of Neuropathic Pain
Lead sponsor
InSightec
Phase
Not applicable
Overall status
Terminated
Start date
October 8, 2020
Completion date
August 3, 2023
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain